Zacks.com featured highlights AMC Global, Lifetime,OptimumBank, EnerSys and First American Financial

Zacks screens 5 stocks (AMC Global Media AMCX, Lifetime Brands LCUT, OptimumBank OPHC, EnerSys ENS, First American Financial FAF) for “alluring” EV-to-EBITDA valuation, arguing lower EV/EBITDA may indicate undervaluation and potential M&A appeal. The article highlights strong expected 2026 earnings growth across the names (e.g., LCUT +156.8% YoY, AMCX +36.5%, OPHC +39.4%, ENS +23.1%, FAF +17.5%), with consensus EPS revisions mostly moving higher over the past 60 days. Overall this is a positive stock-pick/positioning piece, but with limited direct market-moving fundamentals provided.

Analysis

This is more of a positioning/flow event than a true fundamental catalyst. Screens like this can create a short-lived bid in under-owned small caps, but the edge is usually in separating names where the low multiple is a setup for rerating from those where it is a symptom of secular decay or balance-sheet drag. The best quality-to-risk profile in this group is ENS and FAF; they have enough earnings durability that a modest multiple expansion can stick if revisions keep trending up.

The weaker names are the ones where low EV/EBITDA is likely a value trap: AMCX and LCUT need proof that EBITDA is stabilizing, otherwise the market will treat any rally as an exit window. OPHC is even more sensitive to deposit costs and credit normalization, so any move there is likely to fade unless the next quarter confirms margin expansion and asset quality. If the screen catches retail/quant attention, the initial move can be 5-10% in days, but the second-order effect is usually dispersion, not a broad basket rally.

The contrarian miss is that "cheap" is not a catalyst; revision momentum is. FAF and ENS are the only names here where a low multiple can coexist with defensible mid-cycle earnings, while the others may simply be screening cheap because the market is discounting lower terminal cash flows. The thesis is falsified quickly if the next earnings prints do not validate the recent estimate revisions or if housing/industrial demand rolls over before the rerating can compound.

Key Decisions for Investors

• Long ENS / long FAF, funded by short AMCX / short LCUT over the next 1-3 months; target is relative outperformance if revisions persist, with the short leg protecting against a generic value-factor bounce.
• If you want a single-name long, buy FAF only on a pullback after the screen-driven pop; risk/reward is better than chasing AMCX/LCUT because title/transaction volumes can confirm or negate the bullish revision trend within one quarter.
• Avoid initiating fresh long exposure in OPHC until the next earnings release confirms deposit growth and stable NIM; this is a watchlist name, not a conviction trade, because credit quality can reprice the multiple lower very fast.
• Set a stop/alert: if ENS or FAF fail to hold recent estimate revisions into the next print, cut the position—these names work only if the market believes the revisions are durable.
• For more aggressive accounts, use a call spread on FAF rather than stock for a 6-10 week horizon; the setup is a modest rerating, not a structural breakout, so defined-risk upside is preferable.